Across the Americas, a hard question is being weighed in a Washington conference room this week: whether a region that once proved measles could be beaten has begun to lose that hard-won ground. An independent commission of the Pan American Health Organization is reviewing whether the United States, Mexico and Guatemala still interrupt the spread of a disease that had been pushed back for a decade and more. The stakes are less about statistics than about the meaning of a promise kept over decades of vaccination work, now tested by a resurgence that experts describe with a sigh rather than alar
Why the US, Mexico and Guatemala May Lose Their Measles-Free Status
The US is experiencing its largest and deadliest measles outbreak in nearly 30 years, with 57,666 confirmed cases across 17 countries and territories in the Americas from January to October 2026.
A disappointment, not a shock.
Mark
Why does losing this status matter if nothing happens immediately?
Mimi
Because it's a verdict on whether the vaccination gains held. Experts quoted call it a stain on a health programme, and a backslide from a great achievement.
Mark
And it isn't just about how many people got sick?
Mimi
Right. Cases and deaths alone don't decide it. The test is whether one strain spread uninterrupted for at least 12 months.
Luke
How do they know it's one strain? That's the crux.
Mimi
Genetic sequencing, plus epidemiological data on how the virus moved and whether transmission was ever interrupted.
Luke
Then notice that nothing is decided yet. Experts say the US will likely lose it, but Barbosa makes the final call.
Mark
What about Canada?
Mimi
It lost its status last November, so there's already a recent example in the region.
Luke
And Brazil's recovery from 2019 to 2024 is cited, but the doubt about a US response is one expert's view.
Mark
What does the CDC say?
Mimi
Director Erica Schwartz says the approach stays the same: working with the states.
Luke
Whether that's enough is unknown. Ferrari's point about shared language is a hope, not a result.
Der Puls
- A panel of international experts is convening in Washington through Friday, and its verdict could strip three countries of measles elimination status.
- The United States, which has held its status since 2000, faces likely loss after its largest and deadliest outbreak in nearly 30 years, with more than 5,000 cases.
- Regionally, 57,666 confirmed cases have been recorded across 17 countries and territories since January, and Peru and Bolivia are also flagged as at risk.
- Losing status hinges on one strain spreading unbroken for at least 12 months, so investigators are sequencing viruses to trace whether chains of infection were ever interrupted.
- PAHO Director Jarbas Barbosa will announce his final decision early next week, while the US CDC says its approach will not change either way.
Across the Americas, a hard question is being weighed in a Washington conference room this week: whether a region that once proved measles could be beaten has begun to lose that hard-won ground. An independent commission of the Pan American Health Organization is reviewing whether the United States, Mexico and Guatemala still interrupt the spread of a disease that had been pushed back for a decade and more. The stakes are less about statistics than about the meaning of a promise kept over decades of vaccination work, now tested by a resurgence that experts describe with a sigh rather than alarm. A final determination is expected early next week from PAHO's director.
In Washington this week, a panel of international experts has begun deliberating on a question that carries real weight for public health across the Americas: which countries still have measles circulating as an endemic disease. The Pan American Health Organization's Regional Monitoring and Re-Verification Commission will meet through Friday, and its findings could cost the United States, Mexico and Guatemala their measles elimination status.
The Americas were the first region in the world to eliminate endemic measles, in 2016, after decades of vaccination campaigns. The United States has held its own status since 2000. Now it may lose it, after what is described as its largest and deadliest outbreak in nearly 30 years, with sustained transmission since January 2025 and more than 5,000 cases reported by the CDC. Across the region, PAHO has counted 57,666 confirmed cases in 17 countries and territories between January and October 2026.
Losing status is not a matter of counting cases or deaths. A country loses it when the same strain spreads without interruption for at least 12 months. Imported cases from travel do not count against a country in the same way, so investigators use genetic sequencing and study how the virus has moved. The commission also weighs vaccination coverage and how quickly outbreaks are met with a response.
Experts largely expect the US to lose its status. Matt Ferrari called it a disappointment rather than a shock, and Edwin Asturias called it a stain on the country's health programme. No immediate penalties follow, but the burden on public-health systems grows heavier: finding infections, tracing contacts, running labs and organising vaccination drives. Brazil lost its status in 2019 and regained it in 2024 after a focused vaccination campaign, but Asturias does not expect a similar response in the US. The CDC says the status change will not alter its work with the states. Barbosa's decision is expected early next week.
In a conference room in Washington, DC, a panel of international experts began work on Tuesday on a question with real stakes for public health in the Americas: which countries in the region still have measles circulating as an endemic disease. The Regional Monitoring and Re-Verification Commission of the Pan American Health Organization (PAHO) will meet through Friday, and its findings could strip the United States, Mexico and Guatemala of their measles elimination status.
That status means a country has gone at least 12 months without the virus spreading uncontrolled within its borders. The Americas became the first region in the world to eliminate endemic measles transmission, in 2016, after decades of vaccination campaigns. The United States has held its own status since 2000. This year it may lose it, after what is described as its largest and deadliest measles outbreak in nearly 30 years. Sustained outbreaks have been recorded there since January 2025. The US Centers for Disease Control and Prevention has reported more than 5,000 cases, the highest number in 35 years, and a third measles death this year.
The regional picture is just as stark. PAHO counted 57,666 confirmed cases across 17 countries and territories in the Americas between January and October 2026. Besides the US, Mexico, Guatemala, Peru and Bolivia are considered at risk. Canada already lost its status last November. Mexico has also reported prolonged transmission.
The commission is an independent panel of experts in epidemiology, public health and virology that advises PAHO, part of the World Health Organization. It is reviewing reports from all 35 PAHO member states, paying particular attention to countries with prolonged outbreaks, and examining epidemiological data from 2025 and the first half of 2026.
Case counts and deaths alone do not settle the matter. Some cases come from travel exposure, and a limited outbreak sparked that way does not cost a country its status. Under PAHO's criteria, status is lost when the same strain keeps spreading without interruption for at least 12 months in a country or a defined geographic area. Investigators use genetic sequencing to tell whether infections are linked to one strain, and they study how the virus has moved and whether transmission was ever broken. The commission also weighs vaccination coverage, how health systems monitor cases, and how quickly outbreaks are met with a response.
The commission will give recommendations on each country to PAHO Director Jarbas Barbosa, who makes the final determination. An announcement is expected early next week.
Experts largely expect the US to lose its status. Matt Ferrari, director of Pennsylvania State University's Center for Infectious Disease Dynamics, called it "a disappointment, not a shock," and described the backslide from a great public health achievement as heart-wrenching. Edwin Asturias, a professor of infectious disease and epidemiology at the University of Colorado, called it "a stain on your health programme." No immediate penalties follow, but the longer-term burden is heavier demand on public-health systems, which must find infections, trace contacts, run lab tests, isolate patients and organise vaccination drives.
Brazil offers a precedent: it lost its status in 2019 and regained it in 2024 after a strategic vaccination campaign. Asturias does not expect the US to mount a comparably robust response. CDC Director Erica Schwartz told Reuters on Tuesday that losing status would not change the agency's approach, which she said would remain working with the states. Ferrari suggested the announcement could still spur state and local action by giving officials and advocates a shared language. Watch for Barbosa's decision next week, and for what, if anything, changes afterward.
Bemerkenswerte Zitate
It would be a disappointment, not a shock.— Matt Ferrari, Penn State Center for Infectious Disease Dynamics
Losing status would not change the CDC's approach, which remains working with the states.— Erica Schwartz, CDC director, to Reuters (paraphrased)
Möchten Sie die ganze Geschichte?
Das Original lesen bei Al Jazeera ↗